Safety and efficacy of HLA-G–targeted CAR T cells (IVS-3001) in patients with advanced HLA-G–positive solid tumors: Clinical trial in progress.Samer A. Srour, Aung Naing, Matthew T. Campbell et al.|Journal of Clinical Oncology|2025Cited by 2